Jianming Guo
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Immunology top 5%
- Immune Cell Function and Interaction
Papers in
-
- Renal cell carcinoma treatment 56
- Prostate Cancer Treatment and Research 11
- Prostate Cancer Diagnosis and Treatment 8
- Oncology 41
- Cancer Immunotherapy and Biomarkers 28
- Co-authors
- Li Liu (54 shared papers)Jiejie Xu (47 shared papers)Yu Xia (41 shared papers)Qi Bai (42 shared papers)Hang Wang (37 shared papers)Qilai Long (28 shared papers)Ying Xiong (28 shared papers)Xiaoyi Hu (27 shared papers)
- Journals
- Urologic Oncology Seminars and Original Investigations (11 papers)Oncotarget (10 papers)Journal for ImmunoTherapy of Cancer (7 papers)OncoImmunology (7 papers)Cancer Immunology Immunotherapy (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jianming Guo
187 papers receiving 3.9k citations
Jianming Guo's Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 616
- Immunology 753
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 862
- Molecular Biology 1.5k
Countries citing papers authored by Jianming Guo
This map shows the geographic impact of Jianming Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianming Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianming Guo more than expected).
Fields of papers citing papers by Jianming Guo
This network shows the impact of papers produced by Jianming Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianming Guo. The network helps show where Jianming Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianming Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 154 | |
| 2 | 2021 | 153 | |
| 3 | 2002 | 125 | |
| 4 | Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials Hit paper breakdown → | 2023 | 120 |
| 5 | 2019 | 107 | |
| 6 | 2020 | 107 | |
| 7 | 2015 | 101 | |
| 8 | 2016 | 95 | |
| 9 | 2020 | 94 | |
| 10 | 2018 | 88 | |
| 11 | 2002 | 82 | |
| 12 | 2014 | 82 | |
| 13 | 2016 | 81 | |
| 14 | 2020 | 81 | |
| 15 | 2020 | 77 | |
| 16 | 2018 | 71 | |
| 17 | 2020 | 65 | |
| 18 | 2004 | 64 | |
| 19 | 2022 | 62 | |
| 20 | 2023 | 56 |
About Jianming Guo
Jianming Guo is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Immunology and Cancer Research, having authored 191 papers that have together received 4.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (56 papers), Bladder and Urothelial Cancer Treatments (34 papers), Cancer Immunotherapy and Biomarkers (28 papers), Epigenetics and DNA Methylation (12 papers), Prostate Cancer Treatment and Research (11 papers), Immune cells in cancer (11 papers), Renal and related cancers (10 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Cancer Research (616 citations), Immunology (753 citations), Pulmonary and Respiratory Medicine (1.1k citations), Oncology (862 citations) and Molecular Biology (1.5k citations). Jianming Guo has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Li Liu, Jiejie Xu, Yu Xia, Qi Bai, Hang Wang, Qilai Long, Ying Xiong, Xiaoyi Hu, Yanjun Zhu and Yang Qu. Their work appears in journals such as Urologic Oncology Seminars and Original Investigations, Oncotarget, Journal for ImmunoTherapy of Cancer, OncoImmunology and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.